The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Starting January 1, 2017, Humana will cover Cologuard, the FDA-approved multi-target stool DNA test for noninvasive colorectal cancer screening, as an in-network service for its members, most of ...

2. Humana joins several other insurers nationwide that cover the test. Cologuard is now available to more than 153 million members. 3. Since Cologuard’s inclusion as an A-rated service in the ...

Louisville, Ky.-based Humana contracted with Madison, Wis.-based Exact Sciences Corp. to cover Cologuard — a colon cancer test — as an in-network service for its members.

Here are four updates on gastroenterology and endoscopy companies. London-based Lumendi received 510(k) clearance from the FDA for its DiLumen, an endoscopic accessory. Laval, Quebec-based Valeant ...

Humana's Commentary A Humana spokesperson told Benzinga exclusively that starting January 1, 2017, "Humana's Commercial members may be eligible under their plan for the Cologuard test once every ...

Fact checked by Nick Blackmer Cologuard is getting an upgrade soon. An updated at-home screening test, called Cologuard Plus, is expected to be available in June 2025. Cologuard Plus is a more ...

The maker of a new test for colorectal cancer is suing Louisville-based Humana Inc., alleging its denial of payment for screenings performed on more than 4,600 patients violates state and federal ...

Cologuard refers to an at-home stool DNA test that can help screen for colon cancer or polyps. A person enrolled in Medicare aged between 45 and 85 is eligible for coverage for a Cologuard test ...